Curis
CRIS
#11048
Rank
NZ$8.96 M
Marketcap
NZ$0.94
Share price
-15.37%
Change (1 day)
-56.64%
Change (1 year)

Curis (CRIS) - P/B ratio

P/B ratio as of November 2026 : 1.24

According to Curis's latest financial reports the company has a price-to-book ratio of 1.35451.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Curis - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-312.33-150.72%
2024-12-31-4.59-220.08%
2023-12-313.82235.45%
2022-12-311.14-76.31%
2021-12-314.81-13.15%
2020-12-315.54-432.17%
2019-12-31-1.67-67.24%
2018-12-31-5.09-206.34%
2017-12-314.78-67.66%
2016-12-3114.8154.21%
2015-12-315.8234.29%
2014-12-314.33-19.16%
2013-12-315.36-33.08%
2012-12-318.01-10.89%
2011-12-318.99169.02%
2010-12-313.34-49.52%
2009-12-316.62417.62%
2008-12-311.28-3.35%
2007-12-311.32-23.6%
2006-12-311.73-62.54%
2005-12-314.62-9.97%
2004-12-315.139.32%
2003-12-314.70166.31%
2002-12-311.76

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.87 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.20 317.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
7.89 533.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
9.09 630.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.03 143.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
2.22 78.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.8283-33.45%๐Ÿ‡บ๐Ÿ‡ธ USA